Ledger.Open graph →
SEC Form D · filed July 9, 2018

Imbria Pharmaceuticals, Inc

Offering
$40.2M
Sold
$40.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RANCHO SANTA FE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Andrew C. Levin · Rancho Santa Fe, CADirectorPieter C. Boelhouwer · Rancho Santa Fe, CADirectorDavid-Alexandre C. Gros · Rancho Santa Fe, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗